Research in mice describes a molecular mechanism in fatty tissue that predisposes people to regain weight. This finding could help explain the ‘yo-yo effect’ ...
Skipping your dose to over-indulge could leave you “excusing yourself from the table in a hurry,” an expert tells PEOPLE.
Recently, an anonymous female celebrity spoke about why she turned to Ozempic. This inspired another public figure - this ...
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both ...
Recent research in the US has found that those who stop using semaglutide (sold under brand names like Ozempic and WeGovy), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback